147 related articles for article (PubMed ID: 7526363)
1. Down's syndrome screening in multiple pregnancies using alpha-fetoprotein and free beta hCG.
Spencer K; Salonen R; Muller F
Prenat Diagn; 1994 Jul; 14(7):537-42. PubMed ID: 7526363
[TBL] [Abstract][Full Text] [Related]
2. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
Wald NJ; Densem JW
Prenat Diagn; 1994 Aug; 14(8):717-9. PubMed ID: 7527538
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Hsu JJ; Hsieh TT; Soong YK; Spencer K
Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
[TBL] [Abstract][Full Text] [Related]
5. Four-marker serum screening for Down's syndrome.
Wald NJ; Densem JW; Smith D; Klee GG
Prenat Diagn; 1994 Aug; 14(8):707-16. PubMed ID: 7527537
[TBL] [Abstract][Full Text] [Related]
6. Enhanced twin pregnancy detection within an open neural tube defect and Down syndrome screening protocol using free-beta hCG and AFP.
Barnabei VM; Krantz DA; Macri JN; Larsen JW
Prenat Diagn; 1995 Dec; 15(12):1131-4. PubMed ID: 8750293
[TBL] [Abstract][Full Text] [Related]
7. The use of free beta-hCG in antenatal screening for Down's syndrome.
Wald N; Densem J; Stone R; Cheng R
Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
[TBL] [Abstract][Full Text] [Related]
8. Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
Crossley JA; Aitken DA; Waugh SM; Kelly T; Connor JM
Prenat Diagn; 2002 Mar; 22(3):247-55. PubMed ID: 11920904
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
Wald N; Cuckle H; Wu TS; George L
Br J Obstet Gynaecol; 1991 Sep; 98(9):905-8. PubMed ID: 1716981
[TBL] [Abstract][Full Text] [Related]
10. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.
Wald NJ; George L; Smith D; Densem JW; Petterson K
Br J Obstet Gynaecol; 1996 May; 103(5):407-12. PubMed ID: 8624312
[TBL] [Abstract][Full Text] [Related]
11. Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age.
Crossley JA; Aitken DA; Connor JM
Prenat Diagn; 1991 Feb; 11(2):83-101. PubMed ID: 1712100
[TBL] [Abstract][Full Text] [Related]
12. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
Watt HC; Wald NJ; Smith D; Kennard A; Densem J
Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
[TBL] [Abstract][Full Text] [Related]
13. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
14. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Extermann P; Bischof P; Marguerat P; Mermillod B
Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
[TBL] [Abstract][Full Text] [Related]
15. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
16. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK
Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604
[TBL] [Abstract][Full Text] [Related]
17. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
[TBL] [Abstract][Full Text] [Related]
18. The influence of gravidity on Down's syndrome screening with free beta hCG.
Spencer K
Prenat Diagn; 1995 Jan; 15(1):87-9. PubMed ID: 7537879
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum screening for chromosome defects: human chorionic gonadotropin versus its free-beta subunit.
Milunsky A; Nebiolo LM; Bellet D
Fetal Diagn Ther; 1993; 8(4):221-4. PubMed ID: 7505085
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum free alpha- and free beta-human chorionic gonadotrophin in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
Wald NJ; Densem JW; Cheng R; Collishaw S
Prenat Diagn; 1994 Sep; 14(9):835-7. PubMed ID: 7531328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
